Vascular adhesion molecule 1+ fibro-adipogenic progenitors mark fatty infiltration in chronic limb-threatening ischemia

Myosteatosis, the pathological accumulation of fat within skeletal muscle, is increasingly recognized as a critical determinant of adverse clinical outcomes in peripheral arterial disease (PAD). Current therapies for PAD focus on revascularization and risk factor modification, but do not directly target myopathy. There is a critical need for regenerative and cellular therapies to restore muscle integrity and function. This study addresses this need by identifying a candidate causal cellular population, Vcam1<sup>+</sup> fibroadipogenic progenitors, and a signaling axis, Nr3c1-Sfrp1, that promote myosteatosis in the ischemic limb.

Authors

Institutions

Publication Details

Journal
JVS Vascular Science
Published
2025-01-01
DOI
https://doi.org/10.1016/j.jvssci.2025.100295
Primary Topic
Peripheral Artery Disease Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Vascular adhesion molecule 1+ fibro-adipogenic progenitors mark fatty infiltration in chronic limb-threatening ischemia

Brianna Garrett, Kaileen Fei, Yarui Diao, Lindsey A. Olivere et al.
JVS Vascular Science
Peripheral Artery Disease Management
article

Vascular adhesion molecule 1+ fibro-adipogenic progenitors mark fatty infiltration in chronic limb-threatening ischemia

Brianna Garrett, Kaileen Fei, Yarui Diao, Lindsey A. Olivere, Hana Shafique, Christopher D. Kontos, Camryn Johnson, Changxin Wan, Shaghayegh Sadeghmousavi, James Otto, Kevin W. Southerland, Derek Peters, Qunsheng Dai, Leo Akers, Yueyuan Xu, Zhiceng Ji
article en

Abstract

Myosteatosis, the pathological accumulation of fat within skeletal muscle, is increasingly recognized as a critical determinant of adverse clinical outcomes in peripheral arterial disease (PAD). Current therapies for PAD focus on revascularization and risk factor modification, but do not directly target myopathy. There is a critical need for regenerative and cellular therapies to restore muscle integrity and function. This study addresses this need by identifying a candidate causal cellular population, Vcam1<sup>+</sup> fibroadipogenic progenitors, and a signaling axis, Nr3c1-Sfrp1, that promote myosteatosis in the ischemic limb.

JVS Vascular ScienceVol. 6
Duke University (US), Trinity College (CA), Duke Medical Center (US), University of Pittsburgh Medical Center (US), Genetic Technologies (Australia) (AU)
Zero hunger
Openalex Percentile: Top 67%
Peripheral Artery Disease Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Vascular adhesion molecule 1+ fibro-adipogenic progenitors mark fatty infiltration in chronic limb-threatening ischemia — Brianna Garrett, Kaileen Fei, et al. · JVS Vascular Science (2025) | TGRS Research Map | TGRS